180 related articles for article (PubMed ID: 30231723)
1. Reconciling States' "Right to Try" Legislation and FDA's Expanded Access Program: Legal Issues.
Shapiro RS
Ther Innov Regul Sci; 2017 Mar; 51(2):153-156. PubMed ID: 30231723
[TBL] [Abstract][Full Text] [Related]
2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
3. Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program.
Speers MA
Pharmaceut Med; 2019 Apr; 33(2):89-98. PubMed ID: 31933253
[TBL] [Abstract][Full Text] [Related]
4. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Right to Try Act.
Agarwal R; Saltz LB
Clin Cancer Res; 2020 Jan; 26(2):340-343. PubMed ID: 31666248
[TBL] [Abstract][Full Text] [Related]
6. RxLegal: A Rapid Review of Right-To-Try.
Gabay M
Hosp Pharm; 2018 Jul; 53(4):234-235. PubMed ID: 30038441
[TBL] [Abstract][Full Text] [Related]
7. Can Congress Get 'Right to Try' Right?
Kirkner RM
Manag Care; 2018 May; 27(5):10-11. PubMed ID: 29763399
[TBL] [Abstract][Full Text] [Related]
8. Overview of FDA's Expanded Access Program for Investigational Drugs.
Jarow JP; Lurie P; Ikenberry SC; Lemery S
Ther Innov Regul Sci; 2017 Mar; 51(2):177-179. PubMed ID: 28553565
[TBL] [Abstract][Full Text] [Related]
9. A survey of pediatric hematologists/oncologists' perspectives on single patient Expanded Access and Right to Try.
Chapman CR; Belli HM; Leach D; Shah LD; Bateman-House A
Med Access Point Care; 2021; 5():23992026211005991. PubMed ID: 36204503
[TBL] [Abstract][Full Text] [Related]
10. Expanded Access and Right To Try Requests: The Community Oncologist's Experience.
Zettler ME; Jeune-Smith Y; Feinberg BA; Phillips EG; Gajra A
JCO Oncol Pract; 2021 Nov; 17(11):e1719-e1727. PubMed ID: 33886355
[TBL] [Abstract][Full Text] [Related]
11. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
Chapman CR; Eckman J; Bateman-House AS
Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
[TBL] [Abstract][Full Text] [Related]
12. "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.
Smith C; Stout J; Adjei AA; Buckner J; Wentworth M; Tilburt J; Master Z
J Natl Cancer Inst; 2021 Jun; 113(6):735-741. PubMed ID: 32882030
[TBL] [Abstract][Full Text] [Related]
13. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
14. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
Joffe S; Lynch HF
N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
[No Abstract] [Full Text] [Related]
15. Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".
Van Norman GA
JACC Basic Transl Sci; 2018 Apr; 3(2):280-293. PubMed ID: 30062214
[TBL] [Abstract][Full Text] [Related]
16. Oncology Expanded Access and FDA's Project Facilitate.
Scepura B; Chan M; Kim T; Boehmer J; Goldberg KB; Pazdur R
Oncologist; 2021 Oct; 26(10):e1880-e1882. PubMed ID: 34288259
[TBL] [Abstract][Full Text] [Related]
17. Patient advocacy organizations' information for patients on pre-approval access to investigational treatments.
Folkers KM; Leone S; Caplan A
BMC Res Notes; 2019 Oct; 12(1):706. PubMed ID: 31661023
[TBL] [Abstract][Full Text] [Related]
18. Who Stands to Benefit? Right to Try Law Provisions and Implications.
Kearns L; Bateman-House A
Ther Innov Regul Sci; 2017 Mar; 51(2):170-176. PubMed ID: 30231728
[TBL] [Abstract][Full Text] [Related]
19. Federal Right to Try: Where Is It Going?
Folkers K; Chapman C; Redman B
Hastings Cent Rep; 2019 Mar; 49(2):26-36. PubMed ID: 30998281
[TBL] [Abstract][Full Text] [Related]
20. Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.
Meyerson D
J Bioeth Inq; 2017 Sep; 14(3):385-400. PubMed ID: 28634770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
